FINCH THERAPEUTICS GROUP, INC. Operating Cash Flow
FINCH THERAPEUTICS GROUP, INC. reported Operating Cash Flow of -$9.09 million for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-08-13
- FINCH THERAPEUTICS GROUP, INC. net cash provided by (used in) operating activities for the quarter ending 2024-06-30 was -$4.73M.
- FINCH THERAPEUTICS GROUP, INC. net cash provided by (used in) operating activities for the quarter ending 2024-03-31 was -$4.36M.
- FINCH THERAPEUTICS GROUP, INC. net cash provided by (used in) operating activities for the quarter ending 2023-12-31 was -$3.71M.
- FINCH THERAPEUTICS GROUP, INC. net cash provided by (used in) operating activities for the quarter ending 2023-09-30 was -$5.26M.
- FINCH THERAPEUTICS GROUP, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$31.50M.
- FINCH THERAPEUTICS GROUP, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$74.85M.
- FINCH THERAPEUTICS GROUP, INC. net cash provided by (used in) operating activities for fiscal 2021 was -$67.13M.
- FINCH THERAPEUTICS GROUP, INC. net cash provided by (used in) operating activities for fiscal 2020 was -$31.33M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2024-06-30 | -$4.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$9.09M 10-Q · filed 2024-08-13 | -$12.79M derived: sum of 3 quarters · filed 2024-08-13 | -$18.05M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2024-03-31 | -$4.36M 10-Q · filed 2024-05-10 | -$8.07M derived: sum of 2 quarters · filed 2024-05-10 | -$13.33M derived: sum of 3 quarters · filed 2024-05-10 | -$22.49M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-12-31 | -$3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$8.97M derived: sum of 2 quarters · filed 2024-03-25 | -$18.12M derived: sum of 3 quarters · filed 2024-08-13 | -$31.50M 10-K · filed 2024-03-25 | |
| 2023-09-30 | -$5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$14.42M derived: sum of 2 quarters · filed 2024-08-13 | -$27.80M 10-Q · filed 2023-11-08 | -$42.07M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-06-30 | -$9.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$22.54M 10-Q · filed 2024-08-13 | -$36.81M derived: sum of 3 quarters · filed 2024-08-13 | -$55.90M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | -$13.38M 10-Q · filed 2024-05-10 | -$27.65M derived: sum of 2 quarters · filed 2024-05-10 | -$46.75M derived: sum of 3 quarters · filed 2024-05-10 | -$62.59M derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | -$14.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | -$33.37M derived: sum of 2 quarters · filed 2024-03-25 | -$49.20M derived: sum of 3 quarters · filed 2024-03-25 | -$74.85M 10-K · filed 2024-03-25 | |
| 2022-09-30 | -$19.09M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-08 | -$34.93M derived: sum of 2 quarters · filed 2023-11-08 | -$60.58M 10-Q · filed 2023-11-08 | -$74.37M derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | -$15.84M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-08-11 | -$41.48M 10-Q/A · filed 2023-08-11 | -$55.27M derived: sum of 3 quarters · filed 2023-08-11 | -$69.62M derived: sum of 4 quarters · filed 2023-08-11 | |
| 2022-03-31 | -$25.65M 10-Q · filed 2023-05-10 | -$39.43M derived: sum of 2 quarters · filed 2023-05-10 | -$53.78M derived: sum of 3 quarters · filed 2023-05-10 | -$77.56M derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | -$13.79M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$28.14M derived: sum of 2 quarters · filed 2023-03-23 | -$51.92M derived: sum of 3 quarters · filed 2023-03-23 | -$67.13M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$14.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$38.13M derived: sum of 2 quarters · filed 2022-11-10 | -$53.35M 10-Q · filed 2022-11-10 | -$63.63M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | -$23.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$39.00M 10-Q · filed 2022-08-11 | -$39.00M 10-Q · filed 2021-08-10 | -$49.28M derived: sum of 3 quarters · filed 2022-08-11 | -$56.19M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$15.21M 10-Q · filed 2022-05-16 | -$25.50M derived: sum of 2 quarters · filed 2022-05-16 | -$32.41M derived: sum of 3 quarters · filed 2022-05-16 | -$40.57M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | -$10.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$17.20M derived: sum of 2 quarters · filed 2022-03-31 | -$25.36M derived: sum of 3 quarters · filed 2022-03-31 | -$31.33M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$6.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$15.08M derived: sum of 2 quarters · filed 2021-11-10 | -$21.05M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$8.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$14.13M 10-Q · filed 2021-08-10 | |||
| 2020-03-31 | -$5.97M 10-Q · filed 2021-05-13 |